Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$35,052,775
+$7,240,430 QoQ
Shares Held
1,504,411
+8.1% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. INVA ranks #18 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in INVA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,052,775 | 1,504,411 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $27,812,345 | 1,391,313 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $30,143,725 | 1,651,711 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $26,779,286 | 1,332,966 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,490,518 | 137,370 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $5,464,694 | 314,968 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $2,633,594 | 136,385 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,357,932 | 204,752 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $337,977 | 22,177 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $702,538 | 54,083 | Shares | Other | 2023-11-14 | |
| 2022-12-31 | $1,466,655 | 110,691 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $4,596,015 | 395,867 | Shares | Other | 2022-11-14 | |
| 2022-03-31 | $735,590 | 38,015 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $7,669,971 | 444,636 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $8,029,856 | 480,542 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $1,789,586 | 144,438 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,850,469 | 368,466 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,038,395 | 145,808 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,930,039 | 164,119 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||